AU4556699A - Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples - Google Patents

Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples

Info

Publication number
AU4556699A
AU4556699A AU45566/99A AU4556699A AU4556699A AU 4556699 A AU4556699 A AU 4556699A AU 45566/99 A AU45566/99 A AU 45566/99A AU 4556699 A AU4556699 A AU 4556699A AU 4556699 A AU4556699 A AU 4556699A
Authority
AU
Australia
Prior art keywords
monoclonal antibodies
biological samples
antibodies specific
guanidino group
advanced glycosylation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45566/99A
Other languages
English (en)
Inventor
Peter Foiles
Henry W. Founds Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synvista Therapeutics Inc
Original Assignee
Alteon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alteon Inc filed Critical Alteon Inc
Publication of AU4556699A publication Critical patent/AU4556699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU45566/99A 1998-06-09 1999-06-09 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples Abandoned AU4556699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9379998A 1998-06-09 1998-06-09
US09093799 1998-06-09
PCT/US1999/012969 WO1999064463A1 (en) 1998-06-09 1999-06-09 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples

Publications (1)

Publication Number Publication Date
AU4556699A true AU4556699A (en) 1999-12-30

Family

ID=22240797

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45566/99A Abandoned AU4556699A (en) 1998-06-09 1999-06-09 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples

Country Status (4)

Country Link
EP (1) EP1086136A1 (ja)
JP (1) JP2002517224A (ja)
AU (1) AU4556699A (ja)
WO (1) WO1999064463A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120127543A (ko) 2008-05-23 2012-11-21 시와 코퍼레이션 재생을 촉진하는 방법, 조성물 및 장치
ES2725852T3 (es) 2010-09-27 2019-09-27 Siwa Corp Eliminación selectiva de células modificadas por AGE para el tratamiento de la aterosclerosis
US8721571B2 (en) 2010-11-22 2014-05-13 Siwa Corporation Selective removal of cells having accumulated agents
CA2961603C (en) 2014-09-19 2021-07-13 Siwa Corporation Anti-age antibodies for treating inflammation and auto-immune disorders
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
JP6722293B2 (ja) 2016-02-19 2020-07-15 シワ コーポレーション 終末糖化産物（ａｇｅ）に対する抗体を使用して、がんを治療、転移性がん細胞を殺傷、及びがん転移を予防するための方法及び組成物
CA3057829A1 (en) 2016-04-15 2017-10-19 Siwa Corporation Anti-age antibodies for treating neurodegenerative disorders
JP2019518763A (ja) 2016-06-23 2019-07-04 シワ コーポレーション 様々な疾患及び障害の治療において使用するためのワクチン
US10961321B1 (en) 2017-01-06 2021-03-30 Siwa Corporation Methods and compositions for treating pain associated with inflammation
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
US10925937B1 (en) 2017-01-06 2021-02-23 Siwa Corporation Vaccines for use in treating juvenile disorders associated with inflammation
EP3610260A4 (en) * 2017-04-12 2021-01-06 ProterixBio, Inc. COMBINATIONS OF BIOMARKERS TO MONITOR CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHY AND / OR ASSOCIATED MECHANISMS
BR112019021471A2 (pt) 2017-04-13 2020-05-12 Siwa Corporation Anticorpo monoclonal humanizado de produto final da glicação avançada
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0801658B1 (en) * 1994-12-30 2003-07-16 Alteon, Inc. Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples

Also Published As

Publication number Publication date
EP1086136A1 (en) 2001-03-28
JP2002517224A (ja) 2002-06-18
WO1999064463A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
ZA964B (en) Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
AU4556699A (en) Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
AU1550300A (en) Antigen-binding proteins
AU3436695A (en) Reagent for analyzing solid components in urine and method for analyzing solid components by employing the same
IL128406A0 (en) Monoclonal antibodies
EP1071458A4 (en) HUMANIZED ANTIBODIES AND ITS USES
GB9809839D0 (en) Antibody
AU6172096A (en) High affinity human monoclonal antibodies specific for RSV F-protein
ZA200003283B (en) Topical compositions containing whey proteins.
AU5064499A (en) Method for determining hemoglobins
AU3667399A (en) Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof
GR3035008T3 (en) Water-buoyant particulate materials containing micronutrients for phytoplankton
AU3587599A (en) Single chain monoclonal antibody fusion reagents that regulate transcript ion in vivo
AU1631000A (en) Immunoglobulin superfamily proteins
AU4812600A (en) Processing technology for lcm samples
AU676813B2 (en) Element and system for collecting, transporting and storing sample material to be analyzed
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
AU2407899A (en) Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it
AU5441000A (en) Human monoclonal antibody
AU4413597A (en) Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
AU5422599A (en) Method and device for mixing samples near the interface in biosensor systems
AU2452301A (en) Protein methylarginine-specific antibodies
AU2759899A (en) Purified sperm surface antigen, monoclonal antibody therefor and application therefor
GB9818915D0 (en) Antibodies

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase